About Elliott Burkland
Form D filings for SEngine Precision Medicine from 2019 to 2023 list Elliott Burkland as director.
Elliott Burkland first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Elliott Burkland in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Elliott Burkland works with at each company, as listed on that company's latest Form D.
SEngine Precision Medicine, Inc. · Form D, Mar 10, 2023
CK
Christopher Kemp
Executive officer and promoter
PP
Pablo Prichard
Director
TH
Tony Hsu
Executive officer
CG
Carla Grandori
President and CEO, director